Caron’s CEO Doug Tieman and Executive Vice President and Chief Clinical Officer Dave Rotenberg discuss the impact of the opioid crisis on treatment industry employees.
We use cookies to help give you the best experience. By continuing to browse this site, you agree to our use of cookies.
